| News

Innolith makes breakthrough in vehicle batteries

04.04.2019

Energy company Innolith has developed a new type of battery that gives electric vehicles a range of 1,000km. The innovation has now been registered for a patent and will be launched on the market via an initial pilot production.

Innolith Battery

Basel energy company Innolith has developed a battery innovation at its German laboratory in Bruchsal. According to a press release, this rechargeable battery is capable of powering an electric vehicle for over 1,000km on a single charge. The battery avoids exotic and expensive materials and therefore radically reduces overall cost.

In addition to its range and cost advantages, the new battery is also safer. It is the first non-flammable lithium-based battery for use in electric vehicles. Rather than conventional flammable organic electrolytes, the Innolith battery uses a non-flammable inorganic electrolyte.

A patent application has been filed for this battery technology and Innolith is maintaining commercial confidentiality on the cell chemistry mechanism. The chemistry used in this battery has reportedly been proven to operate for more than 55,000 full depth discharge cycles, which is between 10 and 100 times the maximum number of cycles of existing lithium ion batteries in use today.

Innolith will be bringing its Energy Battery to market via an initial pilot production in Germany soon. The aim is to later conclude licensing partnerships with battery manufacturers. BaselArea.swiss supported Innolith in 2018 with the opening of the global headquarters in Basel.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Novartis Campus
Basel Area Business & Innovation, Switzerland Innovation Park

Switzerland Innovation Park Basel Area Site Novartis Campus

We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.

Read More
Basel Area Business & Innovation, Switzerland Innovation Park

The innovation and enterprise campus GRID is filling up

Two institutes from the University of Basel and a pharmaceutical company are relocating to the GRID innovation and enterprise campus, which is currently under construction at BaseLink in Allschwil. The new building will also contain the headquarters of the Switzerland Innovation Park Basel Area in future.

Read More
Basel Area Business & Innovation, Innovation

Artidis ends successful study

Artidis, a startup from Basel, has developed a nanotechnology platform that can be used for cancer diagnosis, among other things. The platform has now been tested in a study that was able to achieve its primary endpoint.

Read More
Basel Area Business & Innovation, Innovation

Startup Academy celebrates anniversary

Startup Academy is on the road to success ten years after being founded. The initiative has supported 280 startups to date. The project was originally started in Basel and is now represented at several locations in Switzerland with plans for further growth.

Read More
Basel Area Business & Innovation, Invest

Syngenta grows strongly and stays true to Basel

Syngenta AG, Adama and Sinochem are to be united under the umbrella of the new Syngenta Group. The group is headquartered in Basel and employs around 48,000 staff across over 100 countries.

Read More
Basel Area Business & Innovation, Innovation

Tolremo raises additional funding

The Muttenz-based biotechnology company Tolremo Therapeutics has raised an additional 4.7 million Swiss francs as part of a financing round. The company develops cancer therapies for precision medicine and is now driving forward clinical development.

Read More
Ruben Herrendorff, CEO Polyneuron Pharmaceuticals
Basel Area Business & Innovation, Innovation

Polyneuron medication receives orphan drug status in the USA

The American health authority has granted Polyneuron’s drug PN-1007 orphan designation. This status uses special conditions to balance out commercial disadvantages when developing drugs for rare diseases.

Read More
Basel Area Business & Innovation, Innovation

BaseLaunch Applications open

BaseLaunch helps build therapeutic ventures to the point where they can raise a Series-A financing round or similar.

Read More
Basel Area Business & Innovation, Innovation

i4Challenge Applications open

The i4Challenge is an acceleration program for SME, startups and new projects focused on innovative solutions, new approaches and next-generation products or services for Industry 4.0.

Read More
Basel Area Business & Innovation, Invest

Ricola earns the trust of Switzerland

Ricola has been voted the most trustworthy brand in Switzerland. The manufacturer of herbal candy, which is based in the Basel Area, previously won this award in 2017.

Read More
1 2 3 19

Do you have a question? We'd like to hear from you.